In Reply to: Plus the FDA has refused to approve formula from any but a handful posted by of companies with regulatory costs-of-entry keeping new companies out of the business. nm on Tue, May 24 2022 at 12:46 PM CDT:
: : : :
Follow Ups:
Post a Followup
Subject:
Comments: : : : : :
Optional Link URL: Link Title: Optional Image URL: